Anne Garnier
Papers
1
Total Citations
20
H-Index
1
About
Dr. Anne Garnier is a leading researcher in cardiac metabolism and mitochondrial biology, whose work has fundamentally advanced our understanding of heart failure. Her research focuses on the molecular mechanisms linking energy metabolism to cardiac function, with a particular emphasis on the transcriptional coactivator PGC-1α. In her landmark 2012 study, "A Cardiac-Specific Robotized Cellular Assay Identified Families of Human Ligands as Inducers of PGC-1α Expression and Mitochondrial Biogenesis," Dr. Garnier developed an innovative high-throughput screening platform to identify compounds capable of restoring PGC-1α expression—a key factor whose decline is central to the metabolic dysfunction seen in heart failure. This pioneering work, which has garnered 20 citations, revealed novel families of human ligands that can induce mitochondrial biogenesis, opening new therapeutic avenues for treating cardiac disease. Her contributions have been instrumental in bridging the gap between basic mitochondrial science and translational cardiology, establishing her as a thought leader in the field. Dr. Garnier’s research continues to inspire new strategies for combating heart failure by targeting the metabolic pathways that sustain cardiac health.
Research Focus
Key Achievements
Top Papers
- 1